Edoxaban
Especificaciones
480449-70-5Número CAS
859-181-7Número CE
N'-(5-chloro-2-pyridinyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamideNombre IUPAC
C24H30ClN7O4SFórmula química
548.1 g/molPeso molecular
EDOXABAN; 480449-70-5; DU-176; NDU3J18APO; CHEBI:85973; DTXSID50197398; N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-amido}cyclohexyl]ethanediamide; edoxabanum; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4-((dimethylamino)carbonyl)-2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-; N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-((5-methyl6,7-dihydro-4H-(1,3)thiazolo(5,4-c)pyridine-2-carbonyl)amino)cyclohexyl)oxamide; N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4H,5H,6H,7H-(1,3)thiazolo(5,4-c)pyridine-2-amido)cyclohexyl)ethanediamide; N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide; N-(5-chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide; RefChem:58094; edoxaban tosilate hydrochloride; B01AF03; DTXCID60119889; 912273-65-5; MFCD13195544; DU-176b; N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide; CHEMBL1269025; N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide; C24H30ClN7O4S; Edoxaban [USAN]; Edoxaban [USAN:INN]; UNII-NDU3J18APO; N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxalamide; 480449-70-5 (free base); Edoxaban (Standard); Edoxaban (USAN/INN); EDOXABAN [INN]; EDOXABAN [MI]; EDOXABAN [MART.]; EDOXABAN [WHO-DD]; SCHEMBL330046; GTPL7575; orb1305585; orb3141300; HSDB 8406; HGVDHZBSSITLCT-JLJPHGGASA-N; GLXC-90139; EX-A5582; BDBM50328731; EBC-27305; HY-10264R; MSK159568; s4429; T2368L; AKOS005146069; CS-1331; DB09075; FC71602; NCGC00378907-01; NCGC00378907-02; NCGC00378907-03; AC-35419; AS-35107; HY-10264; N1-(5-Chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide; SY097689; 5436B; D09710; EN300-20605508; F799088; Q21011234; Z2301684749; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-; N'-(5-chloro-2-pyridinyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N'-(5-chloro-2-pyridyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N'-(5-chloropyridin-2-yl)-N-[(1s,2r,4s)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4h-[1,3] thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide; N(1)-(5-chloropyridin-2-yl)-N(2)-{(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl}ethanediamide; N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carb onyl]amino]cyclohexyl]ethanediamide; N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide; N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl]ethanediamide; N~1~-(5-Chloropyridin-2-yl)-N~2~-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]ethanediamide; N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5, 6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl) ethanediamide; N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide; N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl]ethanediamideSinónimos
Productos que contienen Edoxaban
EDOXABAN NORMON 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEDOXABAN NORMON 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEDOXABAN NORMON 15 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGFientalf 15 mgFientalf 30 mgFientalf 60 mgEdoxbin 60Edoxbin 30Lasaban 15Lasaban 30Lasaban 60Edoxaban Tosylate - IOL Chemicals and Pharmaceuticals
Página 1 de 5
Empresas que venden Edoxaban
CT
Công ty TNHH DRP InterViet NamAP
Aurobindo Pharma LimitedIndiaDR
Dr. Reddy's LaboratoriesIndiaML
MSN LaboratoriesIndiaZS
Zhejiang Supor Pharmaceuticals Co., LTDChinaPágina 1 de 4